![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 2
Zeitschriftenartikel
Weiss, Lena 
ORCID: https://orcid.org/0000-0002-8101-3529; Stintzing, Sebastian ORCID: https://orcid.org/0000-0002-3297-5801; Stahler, Arndt ORCID: https://orcid.org/0000-0003-1041-0137; Westphalen, C. Benedikt ORCID: https://orcid.org/0000-0002-5310-3754; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kiani, Alexander ORCID: https://orcid.org/0000-0002-2494-4087; Vehling-Kaiser, Ursula; Al-Batran, Salah-Edin; Heintges, Tobias; Lerchenmüller, Christian A.; Kahl, Christoph; Seipelt, Gernot; Kullmann, Frank; Heinrich, Kathrin ORCID: https://orcid.org/0000-0003-3580-2313; Holch, Julian Walter ORCID: https://orcid.org/0000-0002-4755-0179; Alig, Annabel ORCID: https://orcid.org/0000-0002-3922-3450; Jung, Andreas ORCID: https://orcid.org/0000-0001-5270-9108; Modest, Dominik Paul und Heinemann, Volker ORCID: https://orcid.org/0000-0002-1349-3321
(15. Mai 2025):
Molecular hyperselection for optimal choice of first-line targeted therapy independent of primary tumor sidedness: An exploratory analysis of the randomized FIRE-3 study performed in RAS wild-type metastatic colorectal cancer.
In: European Journal of Cancer, Bd. 221, 115399
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-8101-3529; Stintzing, Sebastian ORCID: https://orcid.org/0000-0002-3297-5801; Stahler, Arndt ORCID: https://orcid.org/0000-0003-1041-0137; Westphalen, C. Benedikt ORCID: https://orcid.org/0000-0002-5310-3754; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kiani, Alexander ORCID: https://orcid.org/0000-0002-2494-4087; Vehling-Kaiser, Ursula; Al-Batran, Salah-Edin; Heintges, Tobias; Lerchenmüller, Christian A.; Kahl, Christoph; Seipelt, Gernot; Kullmann, Frank; Heinrich, Kathrin ORCID: https://orcid.org/0000-0003-3580-2313; Holch, Julian Walter ORCID: https://orcid.org/0000-0002-4755-0179; Alig, Annabel ORCID: https://orcid.org/0000-0002-3922-3450; Jung, Andreas ORCID: https://orcid.org/0000-0001-5270-9108; Modest, Dominik Paul und Heinemann, Volker ORCID: https://orcid.org/0000-0002-1349-3321
(15. Mai 2025):
Molecular hyperselection for optimal choice of first-line targeted therapy independent of primary tumor sidedness: An exploratory analysis of the randomized FIRE-3 study performed in RAS wild-type metastatic colorectal cancer.
In: European Journal of Cancer, Bd. 221, 115399
[PDF, 1MB]
Heinemann, Volker; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kiani, Alexander; Kaiser, Florian; Al-Batran, Salah-Edin; Heintges, Tobias; Lerchenmüller, Christoph; Kahl, Christoph; Seipelt, Gernot; Kullmann, Frank; Moehler, Markus; Scheithauer, Werner; Held, Swantje; Miller-Phillips, Lisa; Modest, Dominik Paul; Jung, Andreas; Kirchner, Thomas und Stintzing, Sebastian
(2020):
FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial.
In: British Journal of Cancer, Bd. 124, Nr. 3: S. 587-594